ESC Professional Premium Access

Determinants of NT-proBNP Levels in patients with a systemic right ventricle: a new cut-off level for risk stratification?

Congress Presentation

About the speaker

Mr Fabian Tran

St. Claraspital, Basel (Switzerland)
0 follower

6 more presentations in this session

Safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: a prospective cohort study with historical control comparison

Speaker: Doctor A. Kartas (Thessaloniki, GR)

Thumbnail

Dapaglifozin in adults with a systemic right ventricle:initial results from the DAPA-SERVE trial

Speaker: Doctor M. Abbate (Naples, IT)

Thumbnail

Prognostic value and determinants of high sensitive cardiac Troponin levels in patients with a systemic right ventricle: insights from the SERVE-Trial

Speaker: Doctor F. Ruperti Repilado (Basel, CH)

Thumbnail

Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease

Speaker: Doctor R. Luna (Barcelona, ES)

Thumbnail

Adults with congenital heart disease and pulmonary arterial hypertension: Quantitative assessment of haemodynamic parameters under disease targeting therapy - A retrospective multicentre analysis

Speaker: Doctor P. von Stein (Cologne, DE)

Thumbnail

Access the full session

Pharmacotherapy and biomarkers in adult congenital heart disease: do the same rules apply?

Speakers: Mr F. Tran, Doctor A. Kartas, Doctor M. Abbate, Doctor F. Ruperti Repilado, Doctor R. Luna...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations